| Trial ID: | L0004 |
| Source ID: | NCT04475276
|
| Associated Drug: |
Alphalipoic acid
|
| Title: |
Effect of Alpha Lipoic Acid on Non-alcoholic Fatty Liver Diseases
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-Alcoholic Fatty Liver Disease
|
| Interventions: |
Drug: Placebo|Drug: Alphalipoic acid
|
| Outcome Measures: |
Abdominal ultrasound|Insulin resistance|Lipid profile|Levels of glutathione reductase|levels of Cytokeratin-18|Levels of Alanine transaminase (ALT)|Levels of Aspartate transaminase (AST)|Levels of Alkaline phosphatase (ALP)|Levels of Albumin and total protein.|Levels of Bilirubin|Levels of total protein|Levels of Gamma-glutamyltransferase (GGT).|Levels of L-lactate dehydrogenase (LDH).
|
| Sponsor/Collaborators: |
All India Institute of Medical Sciences, Bhubaneswar
|
| Gender: |
All
|
| Age: |
18 Years to 65 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 4
|
| Enrollment: |
120
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment
|
| Start Date: |
February 23, 2021
|
| Completion Date: |
July 31, 2022
|
| Results First Posted: |
--
|
| Last Update Posted: |
July 7, 2021
|
| Locations: |
AIIMS, Bhubaneswar, Odisha, India
|
| URL: |
https://ClinicalTrials.gov/show/NCT04475276
|
